It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Women still struggle to reach leadership positions in pharma. Now that we’ve acknowledged the issue, we can focus on overcoming it.

There are myriad opportunities across different industries for young scientific talent. Why work in the pharma industry?

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.